View up-to-date information on Momenta Pharmaceuticals Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
August 19, 2020 | Johnson & Johnson Acquires Momenta Pharma | Acquisition | Johnson & Johnson | Momenta Pharmaceuticals Inc |
December 12, 2019 | Momenta Pharma Prices Public Offering of Shares for USD225 Million | Equity Offering | - | Momenta Pharmaceuticals Inc |
August 06, 2019 | Momenta Pharmaceuticals Inc Enters Phase II Clinical Trial Agreement with Pharmaceutical Product Development LLC for nipocalimab (GDCT0351342) | Contract Service Agreement | Momenta Pharmaceuticals Inc;Momenta Pharmaceuticals Inc | Pharmaceutical Product Development LLC;Pharmaceutical Product Development LLC |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer